The Potential of Dapagliflozin Plus Exenatide in Obese Insulin-resistant Patients

Conditions:   Obesity;   Diabetes Mellitus, Type 2 Interventions:   Drug: Dapagliflozin 10mg;   Drug: Exenatide 2 mg [Bydureon];   Drug: Placebo Oral Tablet;   Drug: Placebo injection;   Drug: Insulin;   Drug: Metformin, if taken before Sponsors:   Universitätsklinikum Hamburg-Eppendorf;   AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials